Biotech & Health Tech
STAT+: Revolution Medicines’ pancreatic cancer drug has stunning commercial debut
Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.
Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.
This is a summary of the story. Read the full article at Stat News (Biotech & Health Tech) ↗